Evidence map›Paper›PMID 39446222›Full record

ArticleEJNMMI physics2024

360° CZT-SPECT/CT cameras:

Christopher Hoog, Pierre-Malick Koulibaly, Nicolas Sas, Laetitia Imbert, Gilles Le Rouzic, Romain Popoff, Jean-Noël Badel, Ludovic Ferrer

Abstract read
In one paragraph

Article in EJNMMI physics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Optimisation of Q.Clear (BSREM) Reconstruction Parameters forBioengineering (Basel, Switzerland) · 2026
    Article
  2. Quantitative accuracy ofEJNMMI physics · 2026
    Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Christopher HoogMedical Physics Department, Institut Godinot Comprehensive Cancer Center, Reims, France. christopher.hoog@reims.unicancer.fr.ORCID http://orcid.org/0000-0002-7148-6525
Pierre-Malick KoulibalyDepartment of Diagnostic Radiology and Nuclear Medicine, Antoine Lacassagne Comprehensive Cancer Center, Université Nice-Côte d'Azur, 33 Avenue de Valombrose, 06189, Nice, France.
Nicolas SasDepartment of Medical Physics, Jean Perrin Comprehensive Cancer Center, 63000, Clermont-Ferrand, France.
Laetitia ImbertDepartment of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU-Nancy, Université de Lorraine, 54000, Nancy, France.
Gilles Le RouzicNuclear Medicine Department, CHU Orleans, 14 Avenue de l'Hôpital, 45100, Orleans, France.
Romain PopoffDepartment of Medical Physics, Georges-François Leclerc Cancer Center, 1 Rue du Professeur Marion, 21000, Dijon, France.
Jean-Noël BadelCentre de Lutte Contre le Cancer Léon-Bérard, CREATIS CNRS UMR 5220 INSERM U 1044, Université de Lyon, INSA-Lyon, Lyon, France.
Ludovic FerrerMedical Physics Department, ICO René Gauducheau, Saint Herblain, 44805, France.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeFor the first time, three currently available 360° CZT-SPECT/CT cameras were compared under clinical conditions using phantom-based measurements.

methodsA

resultsDespite the higher sensitivity of VERITON cameras and the enhanced energy resolution of the V400 (3.2% at 140 keV, 5.2% at 113 keV, and 3.6% at 208 keV), StarGuide presents comparable image quality. This highlights the need to differentiate sensitivity from count quality, which is influenced by hardware design (collimator, detector block) and conditions image quality as well as the reconstruction process (algorithms, scatter correction, noise regulation). For

conclusionsThe three cameras have equivalent potential for

Indexed as

360° CZT-SPECT/CT camerasMolecular imagingNuclear medicinePhantom studyQuantification

Identifiers

PMID39446222
PMCPMC11502619

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.